Euroapi S.A. (EPA:EAPI)

Market Cap	120.64M -54.0%
Revenue (ttm)	852.60M -7.2%
Net Income	-211.20M
EPS	-2.23
Shares Out	95.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	242,231
Average Volume	400,474
Open	1.290
Previous Close	1.281
Day's Range	1.250 - 1.290
52-Week Range	1.250 - 3.572
Beta	0.60
RSI	11.72
Earnings Date	Mar 3, 2026

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,187
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2025, Euroapi's revenue was 852.60 million, a decrease of -7.25% compared to the previous year's 919.20 million. Losses were -211.20 million, 61.7% more than in 2024.